TICKERNOMICS Sign up
Last Update: 2024-03-28 02:11:38
Pediatrix Medical Group Inc. ( MD ) https://www.mednax.com
9.59USD
Sector:
Healthcare
Industry:
Medical Care Facilities
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
31.15%
-34.00%
MD
SPY
32.74%
-63.13%
MD
SPY
92.93%
-64.70%
MD
SPY
224.41%
-84.39%
MD
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
785.57
750.34
0.47
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
6.99
0.39
0.93
10.87
0.00
3.84
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
7.95
21.10
9.75
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
10.238
9.99
8.47
1.60
Other Earnings and Cash Flow Stats:
Pediatrix Medical Group Inc. ( MD ) Net Income TTM ($MM) is 114.87
Pediatrix Medical Group Inc. ( MD ) Operating Income TTM ($MM) is 173.72
Pediatrix Medical Group Inc. ( MD ) Owners' Earnings Annual ($MM) is 140.49
Pediatrix Medical Group Inc. ( MD ) Current Price to Owners' Earnings ratio is 5.74
Pediatrix Medical Group Inc. ( MD ) EBITDA TTM ($MM) is 209.79
Pediatrix Medical Group Inc. ( MD ) EBITDA Margin is 9.75%
Capital Allocation:
Pediatrix Medical Group Inc. ( MD ) has paid 0.00 dividends per share and bought back 0.102977 million shares in the past 12 months
Pediatrix Medical Group Inc. ( MD ) has reduced its debt by 685.254 million USD in the last 12 months
Capital Structure:
Pediatrix Medical Group Inc. ( MD ) Interest-bearing Debt ($MM) as of last quarter is 68
Pediatrix Medical Group Inc. ( MD ) Annual Working Capital Investments ($MM) are 15
Pediatrix Medical Group Inc. ( MD ) Book Value ($MM) as of last quarter is 849
Pediatrix Medical Group Inc. ( MD ) Debt/Capital as of last quarter is 8%
Other Balance Sheet Stats:
Pediatrix Medical Group Inc. ( MD ) has 73 million in cash on hand as of last quarter
Pediatrix Medical Group Inc. ( MD ) has 388 million of liabilities due within 12 months, and long term debt 636 as of last quarter
Pediatrix Medical Group Inc. ( MD ) has 84 common shares outstanding as of last quarter
Pediatrix Medical Group Inc. ( MD ) has 0 million USD of preferred stock value
Academic Scores:
Pediatrix Medical Group Inc. ( MD ) Altman Z-Score is 1.63 as of last quarter
Pediatrix Medical Group Inc. ( MD ) Piotroski Score is 9.00 as of last quarter
Corporate Governance:
Pediatrix Medical Group Inc. ( MD ) largest shareholder is owning shares at 0.00 ($MM) value
Mary Ann E Moore(an insider) Sold 970 shares of Pediatrix Medical Group Inc. ( MD ) for the amount of $9331.40 on 2023-12-14
2.37% of Pediatrix Medical Group Inc. ( MD ) is held by insiders, and 105.03% is held by institutions
Pediatrix Medical Group Inc. ( MD ) went public on 1995-09-19
Other Pediatrix Medical Group Inc. ( MD ) financial metrics:
FCF:130.94
Unlevered Free Cash Flow:159.88
EPS:1.92
Operating Margin:7.95
Gross Profit Margin:21.10
Div. Payout Ratio%:0.00
Div. Growth YoY%:0.00
Equity Return%:18.97
Beta:1.60
Buffet's Owners Earnings:140.49
Price to Owner's Earnings:5.74
About Pediatrix Medical Group Inc. ( MD ) :
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.